Acid-Base Homeostasis During Vasopressin V2 Receptor Antagonist Treatment in Autosomal Dominant Polycystic Kidney Disease Patients

Gelijkaardige items

• Dose-Titrated Vasopressin V2 Receptor Antagonist Improves Renoprotection in a Mouse Model for Autosomal Dominant Polycystic Kidney Disease
  door: Zittema, Debbie, et al.
  Gepubliceerd in: (2016)
• Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
  door: Messchendorp, A Lianne, et al.
  Gepubliceerd in: (2019)
• Copeptin, a Surrogate Marker of Vasopressin, Is Associated with Disease Severity in Autosomal Dominant Polycystic Kidney Disease
  door: Meijer, Esther, et al.
  Gepubliceerd in: (2011)
• Early Renal Abnormalities in Autosomal Dominant Polycystic Kidney Disease
  door: Meijer, Esther, et al.
  Gepubliceerd in: (2010)
• Author’s Reply to Correspondence: “Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients”
  door: Heida, Judith E., et al.
  Gepubliceerd in: (2021)